Three treatments.
One programme.
Mounjaro, Wegovy and the Wegovy Pill. The medication is only part of it - every option comes with doctor oversight, your own coach and the app for one flat fee.
Check eligibilityAvailable treatments
Mounjaro
tirzepatideMimics two gut hormones to slow digestion and quieten appetite
Wegovy
semaglutideMimics GLP-1 to slow digestion and reduce appetite
Wegovy Pill
oral semaglutideSame active ingredient as Wegovy, taken as a daily tablet
How GLP-1 medications work
Mounjaro, Wegovy and the Wegovy Pill are all GLP-1 medications. They work with your body's own appetite signals rather than against them.
Reduce how much you crave and eat
These treatments mimic the hormones that regulate appetite, so smaller portions feel satisfying and food takes up less mental space.
Slow the pace of stomach emptying
Food leaves the stomach more slowly, which keeps you fuller for longer between meals.
Steady your blood sugar
More stable blood sugar means fewer crashes and fewer of the cravings that come with them.
Who is weight loss medication for?
Eligibility depends on your BMI and health history. Our doctors, all registered with the Irish Medical Council, assess every application and will tell you if medication is not the right route for you.
Common questions
Which treatment will I be prescribed?+
You tell us your history and preferences in the eligibility check, and your Everwell doctor decides what is clinically appropriate. Nothing is prescribed automatically - if injections are not right for you, the Wegovy Pill may be discussed instead.
Can I switch between treatments?+
Yes, under clinical supervision. Switching between GLP-1 medications is common, and your doctor manages the transition. You should only ever take one weight loss medication at a time.
How quickly will I see results?+
Most people notice change within the first few weeks, with more meaningful weight loss over the first three to four months. Doses step up gradually during titration, so early months are as much about your body adjusting as about the number on the scale.
What are the common side effects?+
With GLP-1 treatments the most common are gastrointestinal: nausea, diarrhoea, constipation and reduced appetite. They are usually mild and settle within a couple of weeks. Your doctor and coach are available throughout to help you manage them.
What does the cost cover?+
Your doctor consultation, prescription, medication, monthly doctor reviews, 1:1 coaching with your own human coach, and the app. Delivery is free and fast within Sweden.
References
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine. 2022;387(3):205-216.
- Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine. 2021;384(11):989-1002.
- Wharton S, Lingvay I, Bogdanski P, et al. Oral semaglutide at a dose of 25 mg in adults with overweight or obesity (OASIS 4). New England Journal of Medicine. 2025;393(11):1077-1087.
Medical disclaimer: the information on this page is for educational purposes only and does not replace professional medical advice. Individual results vary. Eligibility and suitability are determined by a registered healthcare professional during consultation.
Not sure which one
is right for you?
Answer a few questions and we'll tell you what you're eligible for, and what it would cost.
Get started →
Sweden’s complete weight-management programme.
Doctor-led care with our own coaching and app.
© Saxonvale Limited. All rights reserved. Everwell is a trading name of Saxonvale Limited. Registered office at 20 Harcourt Street, Dublin 2, Ireland. Registered in Ireland, company number 778251. Healthcare services are provided by Kompas Health Limited (CQC Registration Number: 1-18079642102).
Medicines are dispensed & delivered by Pharmacy Bad Nieuweschans BV (registration number 57429154), Verlengde Hoofdstraat 1D, 9693AB Bad Nieuweschans, Netherlands, with Responsible Pharmacist Albert René Terpstra (registration number 39048698617).